ZebiAI Therapeutics
Chestnut Hill, US · Founded 2019 · Delaware corporation
Founders & leadership
BC
Brant C. BinderNamed on SEC filing
PA
Philip AustinNamed on SEC filing
RW
Richard WagnerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2019
▶$10MraisedJan 2020 · 6 investors · Other TechnologyRule 506(b)
▶$10MraisedJan 2020 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brant C. BinderExecutive Officer, Director
- Philip AustinDirector
- Richard WagnerDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ZebiAI Therapeutics raised?
- ZebiAI Therapeutics has disclosed $10M raised across 1 round.
- Where is ZebiAI Therapeutics headquartered?
- ZebiAI Therapeutics is headquartered in Chestnut Hill, US.